EP4074699 - COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.09.2022 Database last updated on 16.11.2024 | |
Former | The international publication has been made Status updated on 18.06.2021 | Most recent event Tooltip | 19.06.2024 | The date on which the examining division becomes responsible, has been established | 19.06.2024 | Amendment by applicant | Applicant(s) | For all designated states CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. No. 896, Zhongshan East Road High-tech Zone Shijiazhuang, Hebei 050035 / CN | [2022/42] | Inventor(s) | 01 /
WANG, Zhenyu NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 02 /
ZHANG, Yan NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 03 /
MU, Yongzhao NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 04 /
GUO, Jianqiao NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 05 /
AN, Hui NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 06 /
GAO, Na NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 07 /
ZHANG, Chaozai NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | 08 /
WANG, Jia NO. 896, ZHONGSHAN EAST ROAD HIGH-TECH ZONE SHIJIAZHUANG, Hebei 050035 / CN | [2022/42] | Representative(s) | Barrow, Nicholas Martin Venner Shipley LLP 406 Cambridge Science Park Milton Road Cambridge CB4 0WW / GB | [N/P] |
Former [2022/42] | Longland, Emma Louise, et al Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge CB4 0WZ / GB | Application number, filing date | 20898104.3 | 09.12.2020 | [2022/42] | WO2020CN134966 | Priority number, date | CN201911252575 | 09.12.2019 Original published format: CN201911252575 | [2022/42] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021115335 | Date: | 17.06.2021 | Language: | ZH | [2021/24] | Type: | A1 Application with search report | No.: | EP4074699 | Date: | 19.10.2022 | Language: | EN | [2022/42] | Search report(s) | International search report - published on: | CN | 17.06.2021 | (Supplementary) European search report - dispatched on: | EP | 01.12.2023 | Classification | IPC: | C07D401/04, C07D401/12, C07D405/04, C07D405/12, C07D409/12, C07D413/12, C07D417/12, A61K31/444, A61P35/00 | [2022/42] | CPC: |
C07D213/75 (EP);
C07D213/81 (KR,US);
C07D213/74 (US);
A61K31/4418 (KR);
A61K31/444 (KR);
A61P35/00 (EP);
A61P35/02 (KR,US);
C07D401/04 (EP,KR,US);
C07D401/12 (EP,KR,US);
C07D405/04 (EP,KR,US);
C07D405/12 (EP,KR,US);
C07D409/12 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/42] | Title | German: | VERBINDUNG ALS CYCLIN-ABHÄNGIGER KINASE-9-INHIBITOR UND DEREN VERWENDUNG | [2022/42] | English: | COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF | [2022/42] | French: | COMPOSÉ UTILE EN TANT QU'INHIBITEUR DE LA KINASE 9 DÉPENDANTE DE LA CYCLINE ET SON UTILISATION | [2022/42] | Entry into regional phase | 04.07.2022 | Translation filed | 04.07.2022 | National basic fee paid | 04.07.2022 | Search fee paid | 04.07.2022 | Designation fee(s) paid | 04.07.2022 | Examination fee paid | Examination procedure | 04.07.2022 | Examination requested [2022/42] | 19.06.2024 | Amendment by applicant (claims and/or description) | 19.06.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 13.12.2022 | Renewal fee patent year 03 | 19.12.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2011026904 (NOVARTIS AG [CH], et al); | [XI]WO2011026911 (NOVARTIS AG [CH], et al); | [A]US2011224225 (ZEITLMANN LUTZ [DE], et al); | [E]WO2021050824 (PRELUDE THERAPEUTICS INC [US]) |